181 related articles for article (PubMed ID: 1358833)
1. Pharmacokinetic/pharmacodynamic characteristics of the beta-2-agonists terbutaline, salbutamol and fenoterol.
Hochhaus G; Möllmann H
Int J Clin Pharmacol Ther Toxicol; 1992 Sep; 30(9):342-62. PubMed ID: 1358833
[TBL] [Abstract][Full Text] [Related]
2. [Metabolism of beta-adrenergic substances. Therapeutic implications].
Brès J; Clauzel AM; Pistre MC; Rachmat H; Bressolle F
Bull Eur Physiopathol Respir; 1985; 21(5):19s-34s. PubMed ID: 2865990
[TBL] [Abstract][Full Text] [Related]
3. [Effect of beta 2-adrenergic agonists on neurotoxic action of aminophyllines].
Lupina T; Michnar M; Milanowski J; Fafrowicz B
Pneumonol Alergol Pol; 1996; 64 Suppl 1():70-7. PubMed ID: 9190242
[TBL] [Abstract][Full Text] [Related]
4. Effects of beta2 adrenoceptor agonists on T-cell subpopulations.
Holen E; Elsayed S
APMIS; 1998 Sep; 106(9):849-57. PubMed ID: 9808411
[TBL] [Abstract][Full Text] [Related]
5. Glucuronidation of morphine and six beta 2-sympathomimetics in isolated rat intestinal epithelial cells.
Koster AS; Frankhuijzen-Sierevogel AC; Noordhoek J
Drug Metab Dispos; 1985; 13(2):232-8. PubMed ID: 2859174
[TBL] [Abstract][Full Text] [Related]
6. Determination of bioavailability on the basis of tachycardia after intravenous and oral administration of fenoterol, orciprenaline and salbutamol in non-anaesthetized rats.
Muacevic G
Arzneimittelforschung; 1985; 35(1A):406-8. PubMed ID: 2859035
[TBL] [Abstract][Full Text] [Related]
7. Different mechanisms of action of beta2-adrenergic receptor agonists: a comparison of reproterol, fenoterol and salbutamol on monocyte cyclic-AMP and leukotriene B4 production in vitro.
Juergens UR; Stöber M; Libertus H; Darlath W; Gillissen A; Vetter H
Eur J Med Res; 2004 Jul; 9(7):365-70. PubMed ID: 15337638
[TBL] [Abstract][Full Text] [Related]
8. beta-agonistic bronchodilators: comparison of dose/response in working rat hearts.
Zimmer G; Dahinten A; Fitzner A; Halbig S; Noll T; Treusch F; Libertus H
Chest; 2000 Feb; 117(2):519-29. PubMed ID: 10669699
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of beta2-sympathomimetics at the example of fenoterol and conclusion for the administration.
Schmidt EW
Wiad Lek; 1998; 51(1-2):6-10. PubMed ID: 9608824
[TBL] [Abstract][Full Text] [Related]
10. Decrease of plasma potassium due to inhalation of beta-2-agonists: absence of an additional effect of intravenous theophylline.
Deenstra M; Haalboom JR; Struyvenberg A
Eur J Clin Invest; 1988 Apr; 18(2):162-5. PubMed ID: 2898368
[TBL] [Abstract][Full Text] [Related]
11. The cardiovascular effects of beta adrenergic agonist drugs administered by nebulisation.
Flatt A; Crane J; Purdie G; Kwong T; Beasley R; Burgess C
Postgrad Med J; 1990 Feb; 66(772):98-101. PubMed ID: 2349198
[TBL] [Abstract][Full Text] [Related]
12. A comparison of the extent and duration of hypokalaemia following three nebulized beta 2-adrenoceptor agonists.
Burgess CD; Flatt A; Siebers R; Crane J; Beasley R; Purdie G
Eur J Clin Pharmacol; 1989; 36(4):415-7. PubMed ID: 2567672
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic and pharmacodynamic aspects of salmeterol therapy.
Buchwald A; Hochhaus G
Int J Clin Pharmacol Ther; 1998 Dec; 36(12):652-60. PubMed ID: 9877002
[TBL] [Abstract][Full Text] [Related]
14. Clinical-pharmacokinetic aspects of prolonged effect duration as illustrated by beta2-agonists.
Rosenburg J
Eur J Clin Pharmacol; 2002 Jul; 58(4):S1-21. PubMed ID: 12214578
[TBL] [Abstract][Full Text] [Related]
15. Effect of beta-adrenergic agonists on apnea reflexes in newborn lambs.
Grogaard J; Sundell H
Pediatr Res; 1983 Mar; 17(3):213-9. PubMed ID: 6835727
[TBL] [Abstract][Full Text] [Related]
16. New beta 2-adrenergic agonist aerosols.
Kelly HW
Clin Pharm; 1985; 4(4):393-403. PubMed ID: 2864159
[TBL] [Abstract][Full Text] [Related]
17. Influence of adrenergic drugs on IgE production.
Pauwels R; Bazin H; Platteau B; Van Der Straeten M
Int Arch Allergy Appl Immunol; 1980; 61(3):347-51. PubMed ID: 6101578
[TBL] [Abstract][Full Text] [Related]
18. Unsuitability of the human erythrocyte as a model for in vivo sodium transport activation by beta 2 adrenergic agonists.
Siebers RW; Burgess CD; Flatt A; Beasley R; Crane J
Ann Clin Biochem; 1989 Sep; 26 ( Pt 5)():444-6. PubMed ID: 2573312
[TBL] [Abstract][Full Text] [Related]
19. Fenoterol: a beta2-adrenergic agonist for use in asthma. Pharmacology, pharmacokinetics, clinical efficacy and adverse effects.
Svedmyr N
Pharmacotherapy; 1985; 5(3):109-26. PubMed ID: 2991865
[TBL] [Abstract][Full Text] [Related]
20. [Comparative studies on the effect of beta 1- and beta 2-adrenergic agonists on the human adipose-tissue-adenylate-cyclase system].
Kather H; Vogt B; Baumgarten H; Simon B
Med Welt; 1977 Sep; 28(38):1512-3. PubMed ID: 20546
[No Abstract] [Full Text] [Related]
[Next] [New Search]
